CQC report highlights need for continued good practice regarding controlled drugs
The CQC has published its 6th annual report examining the management of controlled drugs. The issue came to light in the Inquiry following Shipman and regulations were introduced to tighten up existing procedures which had effectively allowed Dr Shipman to divert supplies of diamorphine to his patients.
The report covers the control and management of drugs such as controlled drugs, narcotics, amphetamines and anabolic steroids. The report also makes a number of recommendations including the need for health and social care professionals to be aware of their local CDAO- the Controlled Drug Accountable Officer to report any concerns.